These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 20581057)
1. S100A6 overexpression is associated with poor prognosis and is epigenetically up-regulated in gastric cancer. Wang XH; Zhang LH; Zhong XY; Xing XF; Liu YQ; Niu ZJ; Peng Y; Du H; Zhang GG; Hu Y; Liu N; Zhu YB; Ge SH; Zhao W; Lu AP; Li JY; Ji JF Am J Pathol; 2010 Aug; 177(2):586-97. PubMed ID: 20581057 [TBL] [Abstract][Full Text] [Related]
2. Upregulated expression of annexin II is a prognostic marker for patients with gastric cancer. Zhang Q; Ye Z; Yang Q; He X; Wang H; Zhao Z World J Surg Oncol; 2012 Jun; 10():103. PubMed ID: 22681645 [TBL] [Abstract][Full Text] [Related]
3. [Regulation mechanism study of S100A6 on invasion and metastasis in gastric cancer]. Li J; Wang XH; Li ZY; Bu ZD; Wu AW; Zhang LH; Wu XJ; Zong XL; Ji JF Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Nov; 16(11):1096-101. PubMed ID: 24277409 [TBL] [Abstract][Full Text] [Related]
4. S100A6 as a potential serum prognostic biomarker and therapeutic target in gastric cancer. Zhang J; Zhang K; Jiang X; Zhang J Dig Dis Sci; 2014 Sep; 59(9):2136-44. PubMed ID: 24705642 [TBL] [Abstract][Full Text] [Related]
5. Upregulated expression of S100A6 in human gastric cancer. Yang YQ; Zhang LJ; Dong H; Jiang CL; Zhu ZG; Wu JX; Wu YL; Han JS; Xiao HS; Gao HJ; Zhang QH J Dig Dis; 2007 Nov; 8(4):186-93. PubMed ID: 17970874 [TBL] [Abstract][Full Text] [Related]
6. [Expression of S100A6 in primary and metastatic human gastric cancer]. Huang HL; Wu BY; Zhu XD; You WD; Wang WH; Wang MW Zhonghua Zhong Liu Za Zhi; 2008 Jul; 30(7):506-10. PubMed ID: 19062716 [TBL] [Abstract][Full Text] [Related]
7. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma. Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023 [TBL] [Abstract][Full Text] [Related]
8. SAMD14 promoter methylation is strongly associated with gene expression and poor prognosis in gastric cancer. Xu X; Chang X; Xu Y; Deng P; Wang J; Zhang C; Zhu X; Chen S; Dai D Int J Clin Oncol; 2020 Jun; 25(6):1105-1114. PubMed ID: 32206938 [TBL] [Abstract][Full Text] [Related]
9. Epigenetic control of the S100A6 (calcyclin) gene expression. Leśniak W; Słomnicki ŁP; Kuźnicki J J Invest Dermatol; 2007 Oct; 127(10):2307-14. PubMed ID: 17495951 [TBL] [Abstract][Full Text] [Related]
10. Promoter hyper-methylation of calcium binding proteins S100A6 and S100A2 in human prostate cancer. Rehman I; Cross SS; Catto JW; Leiblich A; Mukherjee A; Azzouzi AR; Leung HY; Hamdy FC Prostate; 2005 Dec; 65(4):322-30. PubMed ID: 16015609 [TBL] [Abstract][Full Text] [Related]
11. S100A6 participates in initiation of autoimmune encephalitis and is under epigenetic control. Lin CH; Li SC; Lin MH; Ho CJ; Lu YT; Lin Y; Lin PH; Tsai KW; Tsai MH Brain Behav; 2023 Mar; 13(3):e2897. PubMed ID: 36748983 [TBL] [Abstract][Full Text] [Related]
12. Downregulation of A disintegrin and metallopeptidase with thrombospondin motif type 1 by DNA hypermethylation in human gastric cancer. Chen J; Zhang C; Xu X; Zhu X; Dai D Mol Med Rep; 2015 Aug; 12(2):2487-94. PubMed ID: 25936341 [TBL] [Abstract][Full Text] [Related]
13. Novel tumor-suppressor gene epidermal growth factor-containing fibulin-like extracellular matrix protein 1 is epigenetically silenced and associated with invasion and metastasis in human gastric cancer. Zhu XJ; Liu J; Xu XY; Zhang CD; Dai DQ Mol Med Rep; 2014 Jun; 9(6):2283-92. PubMed ID: 24718752 [TBL] [Abstract][Full Text] [Related]
14. Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers. Zou B; Chim CS; Zeng H; Leung SY; Yang Y; Tu SP; Lin MC; Wang J; He H; Jiang SH; Sun YW; Yu LF; Yuen ST; Kung HF; Wong BC Gastroenterology; 2006 Dec; 131(6):1835-43. PubMed ID: 17087954 [TBL] [Abstract][Full Text] [Related]
15. S100A6 (Calcyclin) is a prostate basal cell marker absent in prostate cancer and its precursors. Rehman I; Cross SS; Azzouzi AR; Catto JW; Deloulme JC; Larre S; Champigneuille J; Fromont G; Cussenot O; Hamdy FC Br J Cancer; 2004 Aug; 91(4):739-44. PubMed ID: 15280928 [TBL] [Abstract][Full Text] [Related]
16. S100A6 promotes cell proliferation in human nasopharyngeal carcinoma via the p38/MAPK signaling pathway. Li A; Shi D; Xu B; Wang J; Tang YL; Xiao W; Shen G; Deng W; Zhao C Mol Carcinog; 2017 Mar; 56(3):972-984. PubMed ID: 27596819 [TBL] [Abstract][Full Text] [Related]
17. S100A6 protein negatively regulates CacyBP/SIP-mediated inhibition of gastric cancer cell proliferation and tumorigenesis. Ning X; Sun S; Zhang K; Liang J; Chuai Y; Li Y; Wang X PLoS One; 2012; 7(1):e30185. PubMed ID: 22295074 [TBL] [Abstract][Full Text] [Related]
18. Reduced Kiss‑1 expression is associated with clinical aggressive feature of gastric cancer patients and promotes migration and invasion in gastric cancer cells. Li C; Yuan L; Han S; Xuan M; Liu D; Tian B; Yu W Oncol Rep; 2020 Sep; 44(3):1149-1157. PubMed ID: 32705229 [TBL] [Abstract][Full Text] [Related]